| Literature DB >> 28608935 |
Vahideh Tarhriz1,2, Kay-Dietrich Wagner3, Zahra Masoumi4,5, Ommoleila Molavi6, Mohammad Saeid Hejazi2,6, Hossein Ghanbarian1,7.
Abstract
Cdk9 is the catalytic core of the positive transcription elongation factor b (P-TEFb) and regulates transcriptional elongation factors by phosphorylation of RNA pol II. Apart from its role on myogenic gene expression, Cdk9 regulation of muscle-specific microRNAs in the early stage of cardiomyogenesis is poorly understood. Here we demonstrate that Cdk9 not only regulates myogenic transcription factors, but also controls muscle-specific microRNAs. During cardiac differentiation of mouse embryonic stem cells, high Cdk9 expression preceded up-regulation of miR-1. To investigate potential regulatory roles of Cdk9 on cardiac microRNAs and myogenesis genes, we overexpressed Cdk9 in myoblast C2C12 cells, which resulted in significant induction of miR-1 and miR-206, while miR-133 was downregulated. Moreover, expression levels of MyoD and Srf, key regulators of myogenesis, also increased in cells with overexpression of Cdk9. We further observed Cdk9-mediated apoptosis in C2C12 cells corresponding to induction of miR-1 expression levels. Thus, Cdk9 plays a complex role in myocyte progenitor differentiation and apoptosis by regulating myogenic protein and muscle-specific microRNA expression. J. Cell. Biochem. 119: 547-554, 2018.Entities:
Keywords: APOPTOSIS; CDK9; IN VITRO DIFFERENTIATION; MYOCYTE PROGENITOR; PROLIFERATION; microRNA
Mesh:
Substances:
Year: 2017 PMID: 28608935 DOI: 10.1002/jcb.26213
Source DB: PubMed Journal: J Cell Biochem ISSN: 0730-2312 Impact factor: 4.429